Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026)
Caribou Biosciences (CRBU) reported EPS (Basic) of -$0.26 for Q1 2026, up 39.53% year-over-year from -$0.19 in Q1 2025, and up 7.14% on a QoQ basis from -$0.28 in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of EPS (Basic) data on file, last reported at -$0.26 in Q1 2026.
- Quarterly EPS (Basic) rose 39.53% year-over-year to -$0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.42 (up 12.35% YoY) and the FY2025 annual result came in at -$1.59, up 3.64% from the prior year.
- EPS (Basic) climbed to -$0.26 in Q1 2026 per CRBU's latest filing, from -$0.28 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.12 in Q3 2023 and bottomed at -$0.58 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.42 (2024), against an average of -$0.39.
- The widest annual swing landed in 2022, when EPS (Basic) jumped 76.98%; it then sank 216.67% in 2024.
- Tracing CRBU's EPS (Basic) over 5 years: stood at -$0.45 in 2022, then climbed by 11.11% to -$0.4 in 2023, then rose by 2.5% to -$0.39 in 2024, then climbed by 28.21% to -$0.28 in 2025, then advanced by 7.14% to -$0.26 in 2026.
- Per Business Quant, the three latest CRBU EPS (Basic) figures stand at -$0.26 (Q1 2026), -$0.28 (Q4 2025), and -$0.3 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.58 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.39 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.48 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | -0.44 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.31 |
| Sep 30, 2021 | -0.46 |
| Jun 30, 2021 | -1.39 |
| Mar 31, 2021 | -1.39 |
| Dec 31, 2020 | -1.68 |
| Sep 30, 2020 | -0.93 |
| Jun 30, 2020 | -0.22 |
| Mar 31, 2020 | -1.16 |